Active Ingredients


Lyophilized Fish Roe


Standardized Ginkgo Biloba Leaf extract


-Libido deficiency & erectile dysfunction

-Male Sub-fertility including low sperm count and poor sperm motility

Mechanism of Action

Cavigen® contains phospholipids that provide a very rich source of Omega 3 fatty acids; DHA & EPA (docosahexanoic & ecosapentanoic acid) that:

-Restores sensitivity of aged Androgen Receptors (ARs) toward Androgen, hence restores deficient

  libido & improves erection

-Improves general sperm parameters including motility, normal morphology and count

-Prevents the damaging effect of reactive oxygen species (ROS) on sperm cells

-Acts as a free radical scavenger

-Antagonizes PAF (platelet aggregating factor) and normalizes blood viscosity

-Improves peripheral and cerebral circulation

Side Effects

Cavigen® contains natural ingredients.

The body recognizes Cavigen® as a natural substance therefore it does not react to it in a negative way.

- No hormone-like adverse effects, does not affect hormonal levels

- Safe for long-term use

- It may rarely cause minor side effects such as stomach upset, gas or headache which usually disappear

  with continuous use

Precautions & Contraindications

 - Cavigen® is safe to use with:

   • Hepatic and/or renal diseases

   • Cardiovascular and respiratory disease

   • Patients on nitrate therapy

   • Gastrointestinal diseases, including Peptic Ulcer and Gastritis

   • Diabetes

   • Patients taking anticoagulants, such as warfarin, should be closely monitored by their physician


For erectile dysfunction and libido deficiency:

-Initial dosage: One capsule 3 times daily after meals

-Maintenance dosage: Once optimal effects are achieved,  dosage can be

  reduced for one capsule daily for maintenance

For Subfertility cases:

-One capsule 3 times daily for three months



-Store at temperature not exceeding 30°C,

  in a dry place

-Keep all medicines out of reach of children

A Jar contains:

15 caps

A Jar contains:

30 caps

All Rights Reserved Liptis Pharmaceuticals 2021